Forums
New posts
Search forums
What's new
New posts
New media
New media comments
Latest activity
Classifieds
Media
New media
New comments
Search media
Log in
Register
What's New?
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More Options
Advertise with us
Contact Us
Close Menu
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Forums
The Water Cooler
General Discussion
No Way To Prevent This, Says Only Nation Where This Regularly Happens
Search titles only
By:
Reply to Thread
This site may earn a commission from merchant affiliate links, including eBay, Amazon, and others.
Message
<blockquote data-quote="Billybob" data-source="post: 2531138" data-attributes="member: 1294"><p>Should repeal of the Mental Health Systems Act in 1980 be mentioned? Or the other predominate change in the treatment of mental illness?</p><p></p><p>In the meantime, psychodynamics, and especially psychoanalysis, which had dominated psychiatric practice in earlier years, lost much of its currency, and psychiatry moved closer to medicine, to the neurosciences, and to biological factors. Medication and short, focused psychotherapy, such as cognitive therapy, replaced much of the earlier Freudian and psychodynamic emphasis. The period 1990&#8211;2000 was declared the decade of the brain, and research in the neurosciences was favored. <strong>During this period Prozac and other selective serotonin reuptake inhibiters (SSRIs) dominated treatment of depression. Although no more effective than earlier antidepressants, they were more acceptable to patients and doctors, and their use increased threefold. Primary care physicians now more commonly medicated patients for depression and anxiety, although this often was inconsistent with practice standards. </strong></p><p></p><p><strong>New atypical antipsychotic drugs were also introduced and aggressively marketed by pharmaceutical companies as more effective and more benign than earlier medications. Psychiatric pharmaceuticals have become a massive business, but recent rigorous clinical trials do not support the optimistic claims of increased effectiveness or benign side effects. </strong>Medication adherence remains an enormous problem. <strong>Medication costs are now the largest component of Medicaid spending for people with mental illnesses. The involvement of pharmaceutical companies in almost every aspect of mental health treatment-including clinical trials, professional education, physician and direct-to-consumer advertising, professional meetings, and designing diagnostic practices and practice standards-raises many concerns about the reliability of the medical literature and practice patterns. </strong></p><p></p><p><a href="http://content.healthaffairs.org/content/26/6/1548.full" target="_blank">http://content.healthaffairs.org/content/26/6/1548.full</a></p><p></p><p><img src="https://www.okshooters.com/data/MetaMirrorCache/makeameme.org_media_created_but_Im_feeling.jpg" alt="" class="fr-fic fr-dii fr-draggable " style="" /></p><p></p><p>What did we learn in a recent thread about shooters and aggression side effects of SSRIs?</p></blockquote><p></p>
[QUOTE="Billybob, post: 2531138, member: 1294"] Should repeal of the Mental Health Systems Act in 1980 be mentioned? Or the other predominate change in the treatment of mental illness? In the meantime, psychodynamics, and especially psychoanalysis, which had dominated psychiatric practice in earlier years, lost much of its currency, and psychiatry moved closer to medicine, to the neurosciences, and to biological factors. Medication and short, focused psychotherapy, such as cognitive therapy, replaced much of the earlier Freudian and psychodynamic emphasis. The period 1990–2000 was declared the decade of the brain, and research in the neurosciences was favored. [B]During this period Prozac and other selective serotonin reuptake inhibiters (SSRIs) dominated treatment of depression. Although no more effective than earlier antidepressants, they were more acceptable to patients and doctors, and their use increased threefold. Primary care physicians now more commonly medicated patients for depression and anxiety, although this often was inconsistent with practice standards. [/B] [B]New atypical antipsychotic drugs were also introduced and aggressively marketed by pharmaceutical companies as more effective and more benign than earlier medications. Psychiatric pharmaceuticals have become a massive business, but recent rigorous clinical trials do not support the optimistic claims of increased effectiveness or benign side effects. [/B]Medication adherence remains an enormous problem. [B]Medication costs are now the largest component of Medicaid spending for people with mental illnesses. The involvement of pharmaceutical companies in almost every aspect of mental health treatment-including clinical trials, professional education, physician and direct-to-consumer advertising, professional meetings, and designing diagnostic practices and practice standards-raises many concerns about the reliability of the medical literature and practice patterns. [/B] [url]http://content.healthaffairs.org/content/26/6/1548.full[/url] [IMG]https://www.okshooters.com/data/MetaMirrorCache/makeameme.org_media_created_but_Im_feeling.jpg[/IMG] What did we learn in a recent thread about shooters and aggression side effects of SSRIs? [/QUOTE]
Insert Quotes…
Verification
Post Reply
Forums
The Water Cooler
General Discussion
No Way To Prevent This, Says Only Nation Where This Regularly Happens
Search titles only
By:
Top
Bottom